Report : North America Patient Registry Software Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Software (Standalone, and Integrated); Database (Public, and Commercial); Type of Registry (Product Registries, Disease Registries, and Health Service Registries); Mode of Delivery (On Premise, and Cloud Based); and Pricing Model (Subscription, and Ownership)
Integrated Segment has the Largest Share of Software in the North America Patient Registry Software Market during 2020–2027
According to a new market research study on “North America Patient Registry Software Market to 2027 – COVID-19 Impact and Regional Analysis and Forecast by Software, Database, Type of Registry, Mode of Delivery, and Pricing Model,” is expected to reach US$ 943.2 million by 2027 from US$ 385.9 million in 2020; it is estimated to grow at a CAGR of 13.6% from 2020 to 2027. The report provides trends prevailing in the North America patient registry software market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the development of digital health infrastructure and increasing use of patient registries are the key factors driving the market growth. However, the market is expected experiencing slow growth during the forecast period owing to the concerns associated with the patient data breach.
The effectiveness of patient registry software to gather and analyze patient data is expected to have constructive impact on the adoption of patient registry software in the region. Moreover, majority of the market players, research centers, and academic institutions are focusing on the adoption of patient registries with an aim to streamline the patient data collection and analysis. In February 2021, the Leukemia & Lymphoma Society (LLS) announced strategic partnership with Ciitizen, a significant player in digital health solution in order to study on the relation between coronavirus and vaccination amongst blood cancer patients. The institution launched LLS National Patient Registry in order to gather data of blood cancer patients for the study. Further, in April 2020, the American Heart Association announced development of a novel patient registry to collect data, which will help the researchers to understand co-relation between coronavirus, cardiovascular diseases, and related treatment protocols. Moreover, in July 2020, Oracle and the National Institutes of Health (NIH) established a patient data registry to gather COVID-19 patients’ data. The partnership has termed this platform as COVID-19 Prevention Network (CoVPN). In addition, in April 2020, IQVIA Inc. announced the launch of a broad and open patient registry platform for advanced understanding and research of covid-19. These developments are likely to have constructive impact on the North America patient registry software market during and post-pandemic period.
The market for patient registry software market is segmented into software, database, type of registry, mode of delivery, and pricing model. In 2019, the integrated software segment accounted for the largest share of the North America patient registry software market. The growth of this market is also attributed to the abilities for integrated software to facilitate informed decision-making, confer appropriate scale-up, capability to handle modern day software solutions, manage application program interface and others. Moreover, integrated software solutions eliminate the need for purchasing separate hardware components as they can be integrated with the existing computer systems, making them more cost-effective and user-friendly.
IQVIA Inc., FIGmd Inc., Medstreaming, Open Text Corporation, Evado Clinical, LUMEDX, CEDARON, IBM Corporation, Mckesson Corporation, and Dacima Software Inc are among the leading companies in the North America patient registry software market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in March 2018, IQVIA and MDA, with the help of its advance technology and infrastructure, are aimed to improve the abilities and capabilities of the researchers and health care service providers. Thus, this collaboration will boost the research opportunities focused on the development of novel drugs. Besides, this union of two organizations is expected to benefit the expansion of the pilot registry, which was established by MDA in 2013.
The report segments the North America Patient Registry Software market as follows:
By Type of Registry
- Product Registry
- Disease Registry
- Cardiovascular Disease Registry
- Health Service Registry
By Mode of Delivery
By Pricing Model
- North America
Contact Person: Sameer Joshi
Email Id: email@example.com